-+ 0.00%
-+ 0.00%
-+ 0.00%

Altimmune Inc. Faces Class Action Lawsuit Following Disappointing Phase 2b Trial Results and Stock Plunge

Reuters·08/18/2025 19:24:16

Please log in to view news